Pharmacokinetic characteristics and safety and tolerability of a reformulated azelastine hydrochloride nasal spray in patients with chronic rhinitis

Bibliography

• Bielory L, Ambrosio P. Conjunctivitis and allergic eye diseases. In: Kaliner MA, editor, Current Reviews of Rhinitis. Philadelphia, PA: Current Medicine, Inc; 2002:115-22
   Google Scholar
• Wallace DV, Dykewicz MS, Bernstein DI, et al. Diagnosis and management of rhinitis: an updated practice parameter. Complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology. Ann Allergy Asthma Immunol 2008;122:S1-84
   Google Scholar
• Settipane RA. Demographics and epidemiology of allergic and nonallergic rhinitis. Allergy Asthma Proc 2001;22:185-9
   PubMed Web of Science ®Google Scholar
• Lieberman P, Kaliner MA, Wheeler WJ. Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis. Curr Med Res Opin 2005;21:611-8
   PubMed Web of Science ®Google Scholar
• Bernstein JA, Rezvani M. Mixed rhinitis: a new subclass of chronic rhinitis? second edition. In: Kaliner MA, editor, Current Reviews of Rhinitis, Philadelphia, PA: Current Medicine, Inc; 2006:69-78
   Google Scholar
• Bernstein JA, Brandt D, Ratner P, Wheeler W. Assessment of a rhinitis questionnaire in a seasonal allergic rhinitis population. Ann Allerg Clin Immunol 2008;100:512-3
   PubMed Web of Science ®Google Scholar
• Lal D, Corey JP. Vasomotor rhinitis update. Curr Opin Otolaryngol Head Neck Surg 2004;12:243-7
   PubMedGoogle Scholar
• Settipane RA. Nonallergic rhinitis. Current Review of Rhinitis. Philadelphia, PA: Current Medicine, Inc; 2002:53-65
   Google Scholar
• Banov CH, Lieberman P. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis. Ann Allergy Asthma Immunol 2001;86:28-35
   PubMed Web of Science ®Google Scholar
• Thompson AK, Juniper E, Meltzer EO. Quality of life in patients with allergic rhinitis. Ann Allergy Asthma Immunol 2000;85:338-47
   PubMed Web of Science ®Google Scholar
• Reed SD, Lee TA, Mccrory DC. The economic burden of allergic rhinitis: a critical evaluation of the literature. Pharmacoeconomics 2004;22:345-61
   PubMed Web of Science ®Google Scholar
• Ray NF, Baraniuk JN, Thamer M, et al. Direct expenditures for the treatment of allergic rhinoconjunctivitis in 1996, including the contributions of related airway illnesses. J Allergy Clin Immunol 1999;103:401-7
   PubMed Web of Science ®Google Scholar
• Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108(5 Suppl):S147-334
   Google Scholar
• Azelastine® (azelastine hydrochloride) nasal spray. US full prescribing information. Meda Pharmaceuticals 2006. Available from: http://www.astelin.com/pdf/astelin_pi.pdf [Accessed October 9, 2008]
   Google Scholar
• Bernstein JA. Azelastine hydrochloride: a review of pharmacology, pharmacokinetics, clinical efficacy, and tolerability. Curr Med Res Opin 2007;23:2441-52
   PubMed Web of Science ®Google Scholar
• Zechel HJ, Brock N, Lenke D, Achterrath-Tuckermann U. Pharmacological and toxicological properties of azelastine, a novel antiallergic agent. Arzneimittelforschung 1981;31:1184-93
   PubMed Web of Science ®Google Scholar
• Meda Pharmaceuticals, Somerset NJ, Data on file, 2007
   Google Scholar
• Takao A, Shimoda T, Matsuse H, et al. Inhibitory effects of azelastine hydrochloride in alcohol-induced asthma. Ann Allergy Asthma Immunol 1999;82:390-4
   PubMed Web of Science ®Google Scholar
• Shin MH, Baroody F, Proud D, et al. The effect of azelastine on the early allergic response. Clin Exp Allergy 1992;22:289-95
   PubMed Web of Science ®Google Scholar
• Nieber K, Baumgarten C, Rathsack R, et al. Effect of azelastine on substance P content in bronchoalveolar and nasal lavage fluids of patients with allergic asthma. Clin Exp Allergy 1993;23:69-71
   PubMed Web of Science ®Google Scholar
• Ito H, Nakamura Y, Takagi S, Sakai K. Effects of azelastine on the level of serum interleukin-4 and soluble CD23 antigen in the treatment of nasal allergy. Arzneimittelforschung 1998;48:1143-7
   PubMed Web of Science ®Google Scholar
• Beck G, Mansur A, Afzal M. Effect of azelastine nasal spray on mediators of inflammation in patients with seasonal allergic rhinitis (SAR). American Academy of Allergy, Asthma, and Immunology 56th Annual Meeting. San Diego, CA; 2000
   Google Scholar
• Ciprandi G, Cosentino C, Milanese M, Tosca MA. Rapid anti-inflammatory action of azelastine eyedrops for ongoing allergic reactions. Ann Allergy Asthma Immunol 2003;90:434-8
   PubMed Web of Science ®Google Scholar
• Ciprandi G, Pronzato C, Passalacqua G, et al. Topical azelastine reduces eosinophil activation and intercellular adhesion molecule-1 expression on nasal epithelial cells: an antiallergic activity. J Allergy Clin Immunol 1996;98:1088-96
   PubMed Web of Science ®Google Scholar
• Busse W, Randlev B, Sedgwick J. The effect of azelastine on neutrophil and eosinophil generation of superoxide. J Allergy Clin Immunol 1989;83:400-5
   PubMed Web of Science ®Google Scholar
• Umeki S. Effects of anti-allergic drugs on human neutrophil superoxide-generating NADPH oxidase. Biochem Pharmacol 1992;43:1109-17
   PubMed Web of Science ®Google Scholar
• Morita M, Ohshima Y, Akutagawa H, et al. Inhibitory effects of azelastine hydrochloride on Ca2+ influx, actin polymerization and release of eosinophil cationic protein of an eosinophilic leukaemia cell line EoL-1. Curr Med Res Opin 1993;13:163-74
   PubMed Web of Science ®Google Scholar
• Nakamura T, Nishizawa Y, Sato T, Yamato C. Effect of azelastine on the intracellular Ca2+ mobilization in guinea pig peritoneal macrophages. Eur J Pharmacol 1988;148:35-41
   PubMed Web of Science ®Google Scholar
• Patel P, D'andrea C, Sacks HJ. Onset of action of azelastine nasal spray compared with mometasone nasal spray and placebo in subjects with seasonal allergic rhinitis evaluated in an environmental exposure chamber. Am J Rhinol 2007;21:499-503
   PubMedGoogle Scholar
• Pearlman DS, Grossman J, Meltzer EO. Histamine skin test reactivity following single and multiple doses of azelastine nasal spray in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2003;91:258-62
   PubMed Web of Science ®Google Scholar
• Ratner PH, Findlay SR, Hampel F Jr, et al. A double-blind, controlled trial to assess the safety and efficacy of azelastine nasal spray in seasonal allergic rhinitis. J Allergy Clin Immunol 1994;94:818-25
   PubMed Web of Science ®Google Scholar
• Storms WW, Pearlman DS, Chervinsky P, et al. Effectiveness of azelastine nasal solution in seasonal allergic rhinitis. Ear Nose Throat J 1994;73:382-9
   PubMedGoogle Scholar
• Laforce C, Dockhorn RJ, Prenner BM, et al. Safety and efficacy of azelastine nasal spray (Azelastine NS) for seasonal allergic rhinitis: a 4-week comparative multicenter trial. Ann Allergy Asthma Immunol 1996;76:181-8
   PubMed Web of Science ®Google Scholar
• Lumry W, Prenner B, Corren J, Wheeler W. Efficacy and safety of azelastine nasal spray at a dose of 1 spray per nostril twice daily. Ann Allergy Asthma Immunol 2007;99:267-72
   PubMed Web of Science ®Google Scholar
• Berger WE, White MV. Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine. Ann Allergy Asthma Immunol 2003;91:205-11
   PubMed Web of Science ®Google Scholar
• Corren J, Storms W, Bernstein JA, et al. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis. Clin Ther 2005;27:543-53
   PubMed Web of Science ®Google Scholar
• Berger W, Hampel F Jr, Bernstein JA, et al. Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2006;97:375-81
   PubMed Web of Science ®Google Scholar
• Weiler JM, Meltzer EO, Benson PM, et al. A dose-ranging study of the efficacy and safety of azelastine nasal spray in the treatment of seasonal allergic rhinitis with an acute model. J Allergy Clin Immunol 1994;94:972-80
   PubMed Web of Science ®Google Scholar
• Meltzer EO, Weiler JM, Dockhorn RJ, et al. Azelastine nasal spray in the management of seasonal allergic rhinitis. Ann Allergy 1994;72:354-9
   PubMedGoogle Scholar
• Allergies in America: a landmark survey of nasal allergy sufferers. Healthstar Communications, Inc. Sponsored by Altana Pharma US, Inc.; March 1, 2006
   Google Scholar
• Physician survey sponsored by the American College of Allergy Asthma and Immunology. Rochester, NY: Harris Interactive Inc.; October 19-21, 2001
   Google Scholar
• Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol 1994;47:81-7
   PubMed Web of Science ®Google Scholar
• Berger WE, White MV. Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine. Ann Allergy Asthma Immunol 2003;91:205-11
   PubMed Web of Science ®Google Scholar
• Laforce CF, Corren J, Wheeler WJ, et al. Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine. Ann Allergy Asthma Immunol 2004;93:154-9
   PubMed Web of Science ®Google Scholar
• Ratner PH, Hampel F, Van Bavel J, et al. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2008;100:74-81
   PubMed Web of Science ®Google Scholar